-
August 28, 2017PREVIEW
Use of canagliflozin (Invokana—Janssen) in patients with type 2 diabetes who had established cardiovascular (CV) disease or CV risk factors resulted in a 14% reduction in the composite endpoint of...
-
June 20, 2017PREVIEW
Use of pioglitazone, an oral thiazolidinedione antihyperglycemic agent, was associated with an increased risk of bone fractures in insulin-resistant, nondiabetic patients with a recent history of...
-
May 16, 2017PREVIEW
Use of once-daily lixisenatide (Adlyxin—Sanofi-Aventis) in older, nonfrail patients whose type 2 diabetes (T2D) was not controlled on their current antidiabetic regimen resulted in improvements in...
-
March 27, 2017PREVIEW
A new position statement by the American Diabetes Association (ADA) focuses on prevention, screening, and management of several diabetic neuropathies, including distal symmetric polyneuropathy (...
-
March 7, 2017PREVIEW
Metformin remains the initial treatment of choice for patients with type 2 diabetes, and if a second agent is needed, clinicians should consider adding a sulfonylurea, a thiazolidinedione, a...
Pages
